Evidence map›Paper›PMID 34176676›Full record

ReviewJournal of cardiothoracic and vascular anesthesia2021

Implementation and Outcomes of a Mobile Extracorporeal Membrane Oxygenation Program in the United States During the Coronavirus Disease 2019 Pandemic.

Mazen F Odish, Cassia Yi, Scott Chicotka, Bradley Genovese, Eugene Golts, Michael Madani, Robert L Owens, Travis Pollema

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of cardiothoracic and vascular anesthesia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mazen F OdishDivision of Pulmonary, Critical Care, and Sleep Medicine, University of California, San Diego, San Diego, CA. Electronic address: modish@health.ucsd.edu.
Cassia YiDepartment of Nursing, University of California, San Diego, San Diego, CA.
Scott ChicotkaDivision of Cardiovascular and Thoracic Surgery, University of California, San Diego, San Diego, CA.
Bradley GenoveseDivision of Cardiovascular and Thoracic Surgery, University of California, San Diego, San Diego, CA.
Eugene GoltsDivision of Cardiovascular and Thoracic Surgery, University of California, San Diego, San Diego, CA.
Michael MadaniDivision of Cardiovascular and Thoracic Surgery, University of California, San Diego, San Diego, CA.
Robert L OwensDivision of Pulmonary, Critical Care, and Sleep Medicine, University of California, San Diego, San Diego, CA.
Travis PollemaDivision of Cardiovascular and Thoracic Surgery, University of California, San Diego, San Diego, CA.
University of California, San Diego · US

Funding

Obstructive Sleep Apnea Endotypes and Impact on Phenotypes of People Living with HIVR01HL142114 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GRANT, IGOR, OWENS, ROBERT LLEWELLYN · 2018 to 2021
$2.0M
Interdisciplinary Anesthesiology Research Training ProgramT32GM121318 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Hemal H Patel, DAVID M ROTH · 2017 to 2026
$1.5M
NHLBI NIH HHS R01 HL142114NIGMS NIH HHS T32 GM121318
6 · The paper itself

Abstract

The coronavirus disease 2019 (COVID-19) pandemic began in the United States around March 2020. Because of limited access to extracorporeal membrane oxygenation (ECMO) in the authors' region, a mobile ECMO team was implemented by April 2020 to serve patients with COVID-19. Several logistical and operational needs were assessed and addressed to ensure a successful program, including credentialing, equipment management, and transportation. A multidisciplinary team was included in the planning, decision-making, and implementation of the mobile ECMO. From April 2020 to January 2021, mobile ECMO was provided to 22 patients in 13 facilities across four southern California counties. The survival to hospital discharge of patients with COVID-19 who received mobile ECMO was 52.4% (11 of 21) compared with 45.2% (14 of 31) for similar patients cannulated in-house. No significant patient or transportation complications occurred during mobile ECMO. Neither the ECMO nor transport teams experianced unprotected exposures to or infections with severe acute respiratory syndrome coronavirus 2. Herein, the implementation of the mobile ECMO team is reviewed, and patient characteristics and outcomes are described.

Indexed as

COVID-19Extracorporeal Membrane OxygenationHumansPandemicsSARS-CoV-2United Statescoronaviruscoronavirus disease 2019COVID-19extracorporeal membrane oxygenationmobile ECMOSARS-CoV-2severe acute respiratory syndrome coronavirus 2transportation

Identifiers

PMID34176676
PMCPMC8152207
OpenAlexW3164873037

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.